AIM To investigate the individual and the combined effects of glutamine, dietary fiber, and growth hormone on the structural adaptation of the remnant small bowel. METHODS Forty-two adult male SpragueDawley rats underwent 85% mid-small bowel resection and received total parenteral nutrition ( T P N ) s u p p o r t d u r i n g t h e f i r s t t h r e e p o s t o p e r a t i o n a l d a y s . F r o m t h e 4 t h postoperational day, animals were randomly assigned to receive 7 different treatments for 8 days: TPNcon group, receiving TPN and enteral 20 g·L -1 glycine perfusion; TPN+Gln group, receiving TPN and enteral 20 g·L -1 glutamine perfusion; ENcon group, receiving enteral nutrition (EN) fortified with 20 g·L -1 glycine; EN+Gln group, enteral nutrition fortified with 20 g·L -1 glutamine; EN+Fib group, enteral nutrition and 2 g·L -1 oral soybean fiber; EN+GH group, enteral nutrition and subcutaneous growth hormone (GH) (0.3IU) injection twice daily; and ENint group, glutamine-enriched EN, oral soybean fiber, and subcutaneous GH injection. RESULTS Enteral glutamine perfusion during TPN increased the small intestinal villus height (jejunal villus height 250 µm ± 29 µm in TPNcon vs 330 µm ± 54 µm in TPN+Gln, ileal villus height 260 µm ± 28 µm in TPNcon vs 330 µm ± 22 µm in TPN+Gln, P<0.05) and mucosa thickness (jejunal mucosa thickness 360 µm ± 32 µm in TPNcon vs 460 µm ± 65 µm in TPN+Gln, ileal mucosa thickness 400µm ± 25 µm in TPNcon vs 490 µm ± 11 µm in TPN+Gln, P<0.05) in comparison with the TPNcon group. Either fiber supplementation or GH administration improved body mass gain (end body weight 270 g ± 3.6 g in EN+Fib, 265.7 g ± 3.3 g in EN+GH, vs 257 g ± 3.3 g in ENcon, P<0.05), elevated plasma insulinlike growth factor (IGF-I) level (880 µg·L -1 ± 52 µg·L -1 in EN+Fib, 1 200 µg·L -1 ± 96 µg·L -1 in EN ± GH, vs 620 µg·L -1 ± 43 µg·L -1 in ENcon, P<0.05), and increased the villus height (jejunum 560 µm ± 44 µm in EN ± Fib, 530 µm ± 30 µm in EN ± GH, vs 450 µm ± 44 µm in ENcon, ileum 400 µm ± 30 µm in EN+Fib, 380 µm ± 49 µm in EN ± GH, vs 320 µm ± 16 µm in ENcon, P<0.05) and the mucosa thickness (jejunum 740 µm ± 66 µm in EN ± Fib, 705 µm ± 27 µm in ENGH, vs 608 µm ± 58 µm in ENcon, ileum 570 µm ± 27 µm in EN ± Fib, 560 µm ± 56 µm in EN ± GH, vs 480 µm ± 40 µm in ENcon, P<0.05) in remnant jejunum and ileum. Glutamine-enriched EN produced little effect in body mass, plasma IGF-I level, and remnant small bowel mucosal structure. The ENint group had greater body mass (280 g ± 2. 2 g), plasma IGF-I level (1450 µg·L -1 ± 137 µg·L -1 ), and villus height (jejunum 620 µm ± 56 µm, ileum 450 µm ± 31 µm) and mucosal thickness (jejunum 800 µm ± 52 µm, ileum 633 µm ± 33 µm) than those in ENcon,EN+Gln (jejunum villus height and mucosa thickness 450 µm ± 47 µm and 610 µm ± 63 µm, ileum villus height and mucosa thickness 330 µm ± 39 µm and 500 µm ± 52 µm), EN+GH groups (P<0.05), and than those in EN+Fib group although no statistical significance was attained. CONCLUSION Both dietary fiber and GH when used separately c...